Skip to main content
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.
Published Web Location
http://europepmc.org/articles/PMC3405223?pdf=renderNo data is associated with this publication.
Abstract
Docetaxel and irinotecan chemotherapy have shown good efficacy in the treatment of advanced oesophago-gastric cancer. This randomised phase II study evaluated the efficacy and toxicity profile of two non-platinum docetaxel-based doublet regimens in advance
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.